Business & Economics

NanoValent Receives Patent for Targeted Polymerized Nanoparticles in Cancer Treatment

NanoValent Pharmaceuticals, a development stage pharmaceutical company progressing a new class of therapeutic anti-cancer agents called targeted nanospheres (TNS),...
Pharmapak 2019

Switzerland overtakes Germany as Europe’s biggest drug delivery innovator, with the UK and France...

As predicted by the ‘European drug delivery and packaging’ report earlier this year, new data shows innovation in drug...

SOPHiA Genetics and ADC Therapeutics Partner for Biomarker Discovery in Pivotal Phase II Clinical...

ADC Therapeutics and SOPHiA GENETICS have entered into a collaboration to identify genomic markers associated with clinical response to...

Rakuten Medical Secures Investment to Develop its Photoimmunotherapy Platform Capabilities and Support Pipeline Growth

Clinical-stage and privately funded biotechnology company Rakuten Medical, previously known as Aspyrian Pharmaceuticals, developing precision-targeted cancer therapies based on...
Featured Image: Lonza, Visp, Switzerland. Courtesy: © 2010 - 2018 Lonza, Visp, Switzerland. Used with permission.

Lonza Expands Bioconjugation Facility for the Commercial Manufacture of Third Antibody-drug Conjugate

Lonza, the Swiss Contract Development and Manufacturing Organization (CDMO), has confirmed the start of expansion to its bioconjugation facility...

Abzena Confirms Successful Technical Transfer of Synaffix’s GlycoConnect™ and HydraSpace™ Technologies

Earlier today Abzena confirmed that it had successfully completed a technology transfer and scalability evaluation using the Synaffix's technologies...
ADC Biotechnology in Deeside, North-Wales, UK. With the availability of a new cleanroom, the company continues its focus on antibody-drug conjugates (ADCs) and developing new process technologies to speed up, simplify and significantly lower the production costs of the latest generation of anticancer blockbuster drugs.

WHP Completes a New State of the Art Cleanroom for ADC Bio

The production of novel antibody-drug conjugates at ADC Biotechnology’s North Wales, United Kingdom, manufacturing plant has been boosted with...
Featured Image: Laboratory Glass works. Courtesy: © 2010 - 2018. Fotolia Used with permission.

SpringWorks and GlaxoSmithKline to Collaborate in the Development of Belantamab Mafodotin

SpringWorks Therapeutics, a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer,...

BioAtla Appoints Eric Sievers, MD, as Chief Medical Officer

BioAtla, a global biotechnology company with operations in San Diego, California, and Beijing, China, focused on the development of...

ImmunoGen to Prioritize Continued Development of Mirvetuximab Soravtansine

Waltham, Massachusetts, based ImmunoGen, expanding field of antibody-drug conjugates (ADCs) with the development of the next generation of targeted...

FEATURED RESOURCES